Unknown EARLY_PHASE1 INTERVENTIONAL 1-arm NCT04801264

Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617

Sponsor: Peking Union Medical College Hospital

Interventions 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617 68Ga-PSMA

Updated 4 times since 2021 Last updated: Mar 18, 2021 Started: Sep 1, 2020 Primary completion: Sep 1, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Adenoid Cystic Carcinoma, this trial is ongoing. The trial is conducted by Peking Union Medical College Hospital and has accumulated 4 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Apr 2023 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Recruiting → Unknown Status
Apr 2021 — Apr 2023 [monthly]

Recruiting EARLY_PHASE1

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China